Literature DB >> 3685877

Long-term follow-up study of patients after endoscopic sphincterotomy for choledocholithiasis.

O Jacobsen1, P Matzen.   

Abstract

Late complications have been examined in 96 patients consecutively treated for choledocholithiasis by endoscopic sphincterotomy in the years 1976 to 1980. Forty-four of the patients (46%) had the gallbladder in situ. Patients treated for short-term complications--that is, in the 1st month after sphincterotomy--are not included in this study. The mean length of follow-up study was 4.1 years (range, 2 months to 8 years and 9 months). Late bile duct symptoms occurred in seven patients (7%): three (6.8%) in patients with the gallbladder in situ and four (7.6%) in cholecystectomized patients. Stones were found in the common bile duct in three of these patients, one with and two without the gallbladder. The median duration from sphincterotomy to late complication was 8 months (range, 2 months to 5 years). Six of the patients had cholangitis, and the seventh had jaundice with abdominal pain. Two of the patients died of their complications. In conclusion, our results indicate that the frequency of late complications to endoscopic sphincterotomy is low and apparently independent of possible prior cholecystectomy.

Entities:  

Mesh:

Year:  1987        PMID: 3685877     DOI: 10.3109/00365528708991933

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  13 in total

1.  Endoscopic retreatment of recurrent choledocholithiasis after sphincterotomy.

Authors:  M Sugiyama; Y Suzuki; N Abe; T Masaki; T Mori; Y Atomi
Journal:  Gut       Date:  2004-12       Impact factor: 23.059

2.  Risk factors of acute cholecystitis after endoscopic common bile duct stone removal.

Authors:  Jun Kyu Lee; Ji Kon Ryu; Joo Kyung Park; Won Jae Yoon; Sang Hyub Lee; Kwang Hyuck Lee; Yong-Tae Kim; Yong Bum Yoon
Journal:  World J Gastroenterol       Date:  2006-02-14       Impact factor: 5.742

3.  Long-term efficacy of endoscopic papillo-sphincterotomy for common bile duct stones and benign papillary stenosis.

Authors:  P A Testoni; A Tittobello
Journal:  Surg Endosc       Date:  1991       Impact factor: 4.584

Review 4.  Endoscopic sphincterotomy in the young patient: is there cause for concern?

Authors:  T C Tham; D L Carr-Locke; J S Collins
Journal:  Gut       Date:  1997-06       Impact factor: 23.059

5.  Papillary dilation vs sphincterotomy in endoscopic removal of bile duct stones. A randomized trial with manometric function.

Authors:  A Minami; T Nakatsu; N Uchida; S Hirabayashi; H Fukuma; S A Morshed; M Nishioka
Journal:  Dig Dis Sci       Date:  1995-12       Impact factor: 3.199

Review 6.  Laparoscopic cholecystectomy and common bile duct stones. The utility of planned perioperative endoscopic retrograde cholangiography and sphincterotomy: experience with 63 patients.

Authors:  S M Graham; J L Flowers; T R Scott; R W Bailey; W A Scovill; K A Zucker; A L Imbembo
Journal:  Ann Surg       Date:  1993-07       Impact factor: 12.969

7.  Endoscopic papillary balloon dilatation may preserve sphincter of Oddi function after common bile duct stone management: evaluation from the viewpoint of endoscopic manometry.

Authors:  H Sato; T Kodama; J Takaaki; Y Tatsumi; T Maeda; S Fujita; Y Fukui; H Ogasawara; S Mitsufuji
Journal:  Gut       Date:  1997-10       Impact factor: 23.059

8.  Effect of medical or surgical admission on outcome of patients with gallstone pancreatitis and common bile duct stones.

Authors:  Jennifer LaFemina; Suzanne M Sokal; Yuchiao Chang; Deborah McGrath; David L Berger
Journal:  J Gastrointest Surg       Date:  2008-07-12       Impact factor: 3.452

9.  Long-term symptoms following endoscopic sphincterotomy for common bile duct stones.

Authors:  R C A Macadam; R J R Goodall
Journal:  Surg Endosc       Date:  2004-01-14       Impact factor: 4.584

10.  Risk factors for cholecystectomy in patients with gallbladder stones after endoscopic clearance of common bile duct stones.

Authors:  Kang-Moon Lee; Chang Nyol Paik; Woo Chul Chung; Jin Dong Kim; Cheong Rok Lee; Jin Mo Yang
Journal:  Surg Endosc       Date:  2009-01-01       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.